Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer
Authors (first, second and last of 5)
The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.
The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
- Official Journal of the German Cancer Society (Deutsche Krebsgesellschaft)
- Publishes significant and up-to-date articles within the fields of experimental and clinical oncology
- Presents original papers, reviews, rapid communications, letters and editorials
- 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Klaus Höffken
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 3.332 (2018)
- Impact factor
- 3.014 (2018)
- Five year impact factor
- 13 days
- Submission to first decision
- 78 days
- Submission to acceptance
- 337,049 (2019)
- Downloads
Latest issue
Latest articles
-
-
Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7/8/9-IL6R)-TLR4 pathway in lung cancer
Authors (first, second and last of 10)
-
Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target
Authors (first, second and last of 13)
-
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
Authors (first, second and last of 10)
-
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Advertisement
About this journal
- Electronic ISSN
- 1432-1335
- Print ISSN
- 0171-5216
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Gale
- Gale Academic OneFile
- Gale InfoTrac
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Oncogenes and Growth Factors Abstracts
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest Research Library
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Psyndex
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- Copyright information
